Autor: |
Levy, Carol J., Raghinaru, Dan, Kudva, Yogish C., Pandit, Keta, Blevins, Thomas, Casaubon, Luis, Desjardins, Donna, Levister, Camilla M., O’Malley, Grenye, Reid, Corey, Lum, John, Kollman, Craig, Beck, Roy W. |
Předmět: |
|
Zdroj: |
Clinical Diabetes; Winter2024, Vol. 42 Issue 1, p116-124, 9p |
Abstrakt: |
The t:slim X2 insulin pump with Control-IQ technology (Control-IQ) advanced hybrid closed-loop automated insulin delivery system was evaluated in this prospective single-arm trial. Thirty adults with type 2 diabetes using the Control-IQ system showed substantial glycemic improvement with no increase in hypoglycemia. Mean time in range (70–180 mg/dL) improved 15%, representing an increase of 3.6 hours/day, and mean glucose decreased by 22 mg/dL. [ABSTRACT FROM AUTHOR] |
Databáze: |
Complementary Index |
Externí odkaz: |
|